
Acute Patient Populations
The crowd matters.
For far too long, we the people who want to give and get better care have had no say in what new ideas get into practice. When you support new ideas here they are over 20 times more likely to get out to market - sometimes incredibly fast. So explore, like, try, pilot, partner, mentor, or invest in these companies and ideas and let's fix healthcare, one awesome idea at a time!
See the companies ↓Fyggy's top 8 in Acute Patient Populations
Ranked by MedStartr Engagement Score.
- 1
LagunaMedStartr Engagement Score34MedStartr Engagement Score34 - 2ObservSMARTMedStartr Engagement Score5MedStartr Engagement Score5
- 2Hicuity HealthMedStartr Engagement Score5MedStartr Engagement Score5
- 2Autonomous HealthcareMedStartr Engagement Score5MedStartr Engagement Score5
- 2Retia MedicalMedStartr Engagement Score5MedStartr Engagement Score5
- 6Stasis LabsMedStartr Engagement Score4MedStartr Engagement Score4
- 6Vitaars (Vitaars)MedStartr Engagement Score4MedStartr Engagement Score4
- 6Physight (ex Alpha Brain)MedStartr Engagement Score4MedStartr Engagement Score4
Companies in Acute Patient Populations
Only accessible to MedStartr community members.
Join now
Laguna
תל אביב-יפו, NY, Israel
Laguna Health is an AI-powered healthcare technology company that enhances care management for patients transitioning home after hospitalization and those with complex care need...
...moreOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowAcute Patient Populations Salon
Share photos and talk with people who care about Acute Patient Populations. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment
